Cerity Partners’s Dynavax Technologies DVAX Stock Holding History

Cerity Partners’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,558	Closed	-$140K	–	2471
2024 Q3	$140K	Buy	+12,558	New	+$138K	﹤0.01%	2385

Other funds holding DVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cerity Partners's DVAX Position: Q4 2024 in Review

Cerity Partners sold out of Dynavax Technologies (DVAX) in Q4 2024, closing a stake of 12,558 shares — an estimated $140K sold.

Cerity Partners first reported a position in DVAX in Q3 2024 and held it in 1 quarter. The position peaked at $140K in Q3 2024. 256 funds tracked by Wall St. Rank hold DVAX as of Q4 2024.

Cerity Partners reported no remaining Dynavax Technologies position as of Q4 2024 after selling out during the quarter.
Cerity Partners sold 12,558 Dynavax Technologies shares in Q4 2024, an estimated $140K.
Cerity Partners first reported a position in Dynavax Technologies in Q3 2024 and held it in 1 quarter.
Cerity Partners's Dynavax Technologies position peaked at $140K in Q3 2024.
256 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2024.

Based on Cerity Partners's 13F filing for Q4 2024, filed 13 Feb 2025.